Is American ready for the next pandemic? The answer is a resounding “no,” according to a recent Washington Post editorial. When the U.S. was caught flat-footed and unprepared to deal with COVID-19, many lawmakers vowed to address pandemic preparedness. Yet, according to many experts, these efforts are inadequate and interest among lawmakers in preparedness has waned as focus has shifted to wars around the world and other geopolitical conflicts.

With bio threats emerging at an accelerating pace, and as biotechnology becomes more available, how can companies and governments address these threats?

Evan is joined by Swati Sureka, Strategic Communications Lead at Ginkgo Bioworks, a U.S. biotech firm that partners with the CDC and other organizations to monitor for emerging pathogens worldwide. She’s the co-author of a new paper laying out a roadmap for a global pathogen surveillance infrastructure, “A New Paradigm for Threat Agnostic Biodetection: Biological Intelligence.”